A 3D in vitro model to explore the inter-conversion between epithelial and mesenchymal states during EMT and its reversion
- PMID: 27255191
- PMCID: PMC4891772
- DOI: 10.1038/srep27072
A 3D in vitro model to explore the inter-conversion between epithelial and mesenchymal states during EMT and its reversion
Abstract
Epithelial-to-mesenchymal transitions (EMT) are strongly implicated in cancer dissemination. Intermediate states, arising from inter-conversion between epithelial (E) and mesenchymal (M) states, are characterized by phenotypic heterogeneity combining E and M features and increased plasticity. Hybrid EMT states are highly relevant in metastatic contexts, but have been largely neglected, partially due to the lack of physiologically-relevant 3D platforms to study them. Here we propose a new in vitro model, combining mammary E cells with a bioengineered 3D matrix, to explore phenotypic and functional properties of cells in transition between E and M states. Optimized alginate-based 3D matrices provided adequate 3D microenvironments, where normal epithelial morphogenesis was recapitulated, with formation of acini-like structures, similar to those found in native mammary tissue. TGFβ1-driven EMT in 3D could be successfully promoted, generating M-like cells. TGFβ1 removal resulted in phenotypic switching to an intermediate state (RE cells), a hybrid cell population expressing both E and M markers at gene/protein levels. RE cells exhibited increased proliferative/clonogenic activity, as compared to M cells, being able to form large colonies containing cells with front-back polarity, suggesting a more aggressive phenotype. Our 3D model provides a powerful tool to investigate the role of the microenvironment on metastable EMT stages.
Figures







Similar articles
-
TGF-β1 Induces EMT in Bovine Mammary Epithelial Cells Through the TGFβ1/Smad Signaling Pathway.Cell Physiol Biochem. 2017;43(1):82-93. doi: 10.1159/000480321. Epub 2017 Aug 25. Cell Physiol Biochem. 2017. PMID: 28848180
-
GSK3β attenuates TGF-β1 induced epithelial-mesenchymal transition and metabolic alterations in ARPE-19 cells.Biochem Biophys Res Commun. 2017 May 6;486(3):744-751. doi: 10.1016/j.bbrc.2017.03.113. Epub 2017 Mar 22. Biochem Biophys Res Commun. 2017. PMID: 28342867
-
Keratin 13 gene is epigenetically suppressed during transforming growth factor-β1-induced epithelial-mesenchymal transition in a human keratinocyte cell line.Biochem Biophys Res Commun. 2018 Feb 5;496(2):381-386. doi: 10.1016/j.bbrc.2018.01.047. Epub 2018 Jan 8. Biochem Biophys Res Commun. 2018. PMID: 29326042
-
Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):149-68. doi: 10.1007/s10911-010-9180-2. Epub 2010 May 12. J Mammary Gland Biol Neoplasia. 2010. PMID: 20461450 Review.
-
Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer.Oncogene. 2023 Jul;42(29):2237-2248. doi: 10.1038/s41388-023-02749-9. Epub 2023 Jun 21. Oncogene. 2023. PMID: 37344626 Free PMC article. Review.
Cited by
-
Engineering a Vascularized 3D Hybrid System to Model Tumor-Stroma Interactions in Breast Cancer.Front Bioeng Biotechnol. 2021 Mar 11;9:647031. doi: 10.3389/fbioe.2021.647031. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 33791288 Free PMC article.
-
Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells.PLoS One. 2017 Jul 6;12(7):e0180383. doi: 10.1371/journal.pone.0180383. eCollection 2017. PLoS One. 2017. PMID: 28683123 Free PMC article.
-
Fibrotic extracellular matrix preferentially induces a partial Epithelial-Mesenchymal Transition phenotype in a 3-D agent based model of fibrosis.Math Biosci. 2025 Mar;381:109375. doi: 10.1016/j.mbs.2025.109375. Epub 2025 Jan 18. Math Biosci. 2025. PMID: 39832653
-
3D collagen fibrillar microstructure guides pancreatic cancer cell phenotype and serves as a critical design parameter for phenotypic models of EMT.PLoS One. 2017 Nov 30;12(11):e0188870. doi: 10.1371/journal.pone.0188870. eCollection 2017. PLoS One. 2017. PMID: 29190794 Free PMC article.
-
The epithelial-mesenchymal transition and the cytoskeleton in bioengineered systems.Cell Commun Signal. 2021 Mar 10;19(1):32. doi: 10.1186/s12964-021-00713-2. Cell Commun Signal. 2021. PMID: 33691719 Free PMC article. Review.
References
-
- Yang J. & Weinberg R. A. Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis. Dev Cell 14, 818–829 (2008). - PubMed
-
- Thiery J. P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2, 442–454 (2002). - PubMed
-
- Brabletz T. EMT and MET in Metastasis: Where Are the Cancer Stem Cells? Cancer Cell 22, 699–701 (2012). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources